289677-10-7 Usage
Uses
Used in Pharmaceutical Industry:
(R)-4-Benzyl-3-(3-cyclopentyl-propionyl)-oxazolidin-2-one is used as a chiral building block for the synthesis of various biologically active molecules. Its unique stereochemistry and functional properties, contributed by the cyclopentyl and benzyl groups, make it a valuable component in the development of new pharmaceutical compounds with potential therapeutic applications.
Used in Materials Science:
(R)-4-Benzyl-3-(3-cyclopentyl-propionyl)-oxazolidin-2-one is used in materials science for its potential applications in the development of new materials with specific properties. Its unique structure and chemical properties can be utilized to create materials with tailored characteristics for various applications.
Used in Organic Synthesis:
(R)-4-Benzyl-3-(3-cyclopentyl-propionyl)-oxazolidin-2-one serves as a starting material in organic synthesis, allowing chemists to create a wide range of compounds with diverse functionalities. Its versatility and unique properties make it an essential component in the synthesis of complex organic molecules for various applications in research and industry.
Check Digit Verification of cas no
The CAS Registry Mumber 289677-10-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,8,9,6,7 and 7 respectively; the second part has 2 digits, 1 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 289677-10:
(8*2)+(7*8)+(6*9)+(5*6)+(4*7)+(3*7)+(2*1)+(1*0)=207
207 % 10 = 7
So 289677-10-7 is a valid CAS Registry Number.
InChI:InChI=1/C18H23NO3/c20-17(11-10-14-6-4-5-7-14)19-16(13-22-18(19)21)12-15-8-2-1-3-9-15/h1-3,8-9,14,16H,4-7,10-13H2/t16-/m1/s1
289677-10-7Relevant articles and documents
Hydroxyalkanoylaminolactams and related structures as inhibitors of A-beta protein production
-
, (2008/06/13)
This invention relates to novel lactams having the formula (I): to their pharmaceutical compositions and to their methods of use. These novel compounds inhibit the processing of amyloid precursor protein and, more specifically, inhibit the production of A
Hydroxyalkanoylaminolactams and related structures as inhibitors of a β protein production
-
, (2008/06/13)
This invention relates to novel lactams having the formula (I): to their pharmaceutical compositions and to their methods of use. These novel compounds inhibit the processing of amyloid precursor protein and, more specifically, inhibit the production of A
Hydroxyalkanoylaminolactams and related structures as inhibitors of a beta protein production
-
, (2008/06/13)
This invention relates to novel lactams having the formula (I): to their pharmaceutical compositions and to their methods of use. These novel compounds inhibit the processing of amyloid precursor protein and, more specifically, inhibit the production of A